ActiTrexx GmbH | Finanzwire

Basculer en Français

11219	Companies
248788	Keywords
176578	Articles
134626	Press releases

Home
Companies
ActiTrexx GmbH

BRIEF

published on 10/20/2025 at 10:05, 1 year ago

ActiTrexx Completes Final Patient Treatment in GvHD Therapy Study

Clinical Study Graft-versus-Host Disease Actileucel Immune Therapy Regulatory T Cells
PRESS RELEASE

published on 10/20/2025 at 10:00, 1 year ago

ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention

ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel Phase Ib/II Study
BRIEF

published on 03/19/2024 at 10:05, 2 years 7 months ago

ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy

Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
PRESS RELEASE

published on 03/19/2024 at 10:00, 2 years 7 months ago

ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment

Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study

Accesswire

Published on 10/23/2026 at 02:20, 8 hours 55 minutes ago

Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 11 hours 45 minutes ago

Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 12 hours 45 minutes ago

Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 19 hours 15 minutes ago

Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 20 hours 45 minutes ago

Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components

View all ACCESSWIRE

EQS Group

Published on 10/23/2026 at 11:00, 15 minutes ago

Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market
Published on 10/23/2026 at 10:58, 16 minutes ago

How can digitalization improve healthcare?
Published on 10/23/2026 at 10:18, 56 minutes ago

Schirp Schjmidt-Morsbach Rechtsanwälte PartG: Investor Lawsuits in the Wirecard Case: Federal Court of Justice Dismisses EY from Model Proceedings The lead plaintiff’s attorneys welcome the decision
Published on 10/23/2026 at 10:05, 1 hour 10 minutes ago

SINEXCEL Achieves IEC 62443-4-1 Certification for Cybersecurity Compliance
Published on 10/23/2026 at 09:00, 2 hours 15 minutes ago

Municipality Finance issues a USD 135 million tap under its MTN programme

Les Echos

Published on 10/23/2026 at 07:00, 4 hours 15 minutes ago

Safran reports third quarter 2026 revenue
Published on 10/22/2026 at 18:00, 17 hours 15 minutes ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 17 hours 15 minutes ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 17 hours 15 minutes ago

H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 17 hours 28 minutes ago

Aéroports de Paris SA - 2026 9-month revenue

View all LES ECHOS COMFI WIRE